Remember Martin Shkreli? The CEO who purchased the rights for Daraprim and swiftly raised prices from $13.50 to $750 per pill? Well, he’s being undercut by another pharmaceutical company.
The Associated Press reports that San Diego-based Imprimis Pharmaceuticals Inc. has begun selling pills containing Daraprim’s active ingredients, pyrimethamine and leucovorin, for $99 in 100-capsule bottles. This is a major relief for cancer and AIDS patients, who use the drug to help fight off parasitic infections that attack their weakened immune systems.
“We are looking at all of these cases where the sole-source generic companies are jacking the price way up,” Imprimis CEO Mark Baum said. “There’ll be many more of these” compounded drugs coming in the near future.
Baum also said the company will work with health insurers and prescription benefit managers throughout the country to make sure their version of Daraprim and other compounded generic medicines are widely available for consumers. You can purchase the new pills on their website.